SCHEMBL13765796

SCHEMBL13765796

COc1cc(F)c(C(C)(C)CF)c(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.46
ALDH1A1 P00352 1/20 0.39
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CYP1A2 P05177 3/20 0.35
CYP1A1 P04798 2/20 0.35
CYP1B1 Q16678 2/20 0.35
AKR1C3 P42330 1/20 0.33
AKR1C2 P52895 1/20 0.33
KIF11 P52732 2/20 0.32
NQO2 P16083 1/20 0.32
KDM1A O60341 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
CYP3A4 P08684 1/20 0.30
CPS1 P31327 1/20 0.30
FFAR1 O14842 1/20 0.30
FFAR4 Q5NUL3 1/20 0.30
CALM1 P0DP23 1/20 0.30
GRM8 O00222 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13765722 0.82 TAAR1 (0.44) TAAR1ALDH1A1CA1CA2CYP1A2
SCHEMBL13766030 0.81 TAAR1 (0.43) TAAR1ALDH1A1CA1CA2CYP1A2
SCHEMBL10202032 0.79 TAAR1 (0.47) TAAR1ALDH1A1CA1CA2CYP1A2
SCHEMBL14767338 0.74 TAAR1 (0.47) TAAR1ALDH1A1CA1CA2CYP1A2
SCHEMBL1474395 0.73 TAAR1 (0.42) TAAR1ALDH1A1CA1CA2CYP1A2
SCHEMBL22043270 0.72 TAAR1 (0.41) TAAR1ALDH1A1CA1CA2CYP1A2
SCHEMBL25946862 0.72 TAAR1 (0.41) TAAR1ALDH1A1CA1CA2CYP1A2
SCHEMBL1476208 0.71 HSD11B1 (0.41) TAAR1ALDH1A1CA1CA2CYP1A2
SCHEMBL1474459 0.71 TAAR1 (0.40) TAAR1ALDH1A1CA1CA2CYP1A2
SCHEMBL13547867 0.69 TAAR1 (0.57) TAAR1ALDH1A1CA1CA2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7566739-B2 Substituted N-sulfonylaminophenylethyl-2-phenoxyacetamide compounds as VR1 receptor antagonists PFIZER INC. (US) 2009-07-28 US disclosed